4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-065844
Chief Scientific Officer sold 1,319 shares at an average $64.81 ($85,483)
- Chief Scientific Officer acquired 4,445 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garfield Alastair Chief Scientific Officer | 2025-07-01 | Option exercise 10b5-1 | +4,445 | 4,445 | D | ||
| Garfield Alastair Chief Scientific Officer | 2025-07-02 | Sale 10b5-1 | −1,313 | $64.81 | $85,096 | 3,132 | D |
| Garfield Alastair Chief Scientific Officer | 2025-07-02 | Sale 10b5-1 | −6 | $64.60 | $388 | 3,126 | D |
| Derivatives | |||||||
| Garfield Alastair Chief Scientific Officer | 2025-07-01 | Option exercise · Restricted Stock Units 10b5-1 | −4,445 | 13,333 | D | ||
| Open-market sales · 1,319 sh · avg $64.81 · $85,483 | |||||||
Loading xslF345X05/tm2519881-1_4seq1.xml…